Parent-Based Intervention for Childhood Avoidant/Restrictive Food Intake Disorder (ARFID)
This study aims to test the efficacy of a parent-based approach to treating Avoidant/Restrictive Food Intake Disorder (ARFID) in children, SPACE-ARFID (Supportive Parenting for Anxious Childhood Emotions, adapted for ARFID), by comparing it to Nutritional Support (NS). The study design is a randomized controlled trial with 2 treatment arms and 3 assessment points (pre, post, and follow-up) using questionnaire data and clinical interviews.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
The primary objective is to examine if SPACE-ARFID is more efficacious than NS in reducing adolescent ARFID symptoms. The secondary objective is to examine if SPACE-ARFID produces greater change than NS in improving family accommodation and family functioning. SPACE and NS will be delivered over 16-20 weekly sessions, pre-assessment will take place before sessions begin and post-assessment will take place once sessions end, there will also be a midpoint assessment halfway through treatment (sessions 8-10) and one more follow-up assessment 6 months later.
Tipo de estudo
Tipo de estudo
Inscrição (Estimado)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
Contato de estudo
- Nome: Alison Magnotti, MA
- Número de telefone: 203-737-4644
- E-mail: alison.magnotti@yale.edu
Estude backup de contato
- Nome: Eli Lebowitz, PhD
- Número de telefone: 203-737-4644
- E-mail: eli.lebowitz@yale.edu
Locais de estudo
-
-
Connecticut
-
New Haven, Connecticut, Estados Unidos, 06519
- Yale Child Study Center
-
Contato:
- Eli Lebowitz, PhD
- Número de telefone: 203-737-4644
- E-mail: eli.lebowitz@yale.edu
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Be between 6 and 12 years old.
- Meet DSM-5 diagnostic criteria for ARFID, as determined by the PARDI diagnostic interview.
- Cease all other psychotherapeutic treatment targeting eating or feeding behaviors, upon consultation with project staff and the current service provider.
- Not currently use any psychotropic medication, unless on a stable dose for a minimum of 4 weeks prior to enrollment; no changes anticipated during the course of the study.
- BMI at or above the 5th percentile for age and sex.
- Have an eligible and willing participating parent (see parent exclusions below).
Exclusion Criteria:
Adolescents:
- Meet criteria for any other DSM-5 disorder as determined by the ADIS diagnostic interview and health history form, that is sufficiently impairing or disruptive so as to make treatment focused on ARFID not feasible.
- Have any of the following disorders: intellectual disability; bipolar disorder; schizophrenia and other psychotic disorders; and alcohol and substance use disorders, as determined by the health history form.
- Report a suicide attempt in the last 3 months, or current suicide intent and/or plans.
- Be a victim of past or present undisclosed abuse requiring investigation or ongoing supervision by the Department of Children and Families.
- Not have sufficient proficiency in English to complete assessments.
- Require a level of medical care for nutritional compromise that exceeds what can be safely provided in an outpatient setting.
Parents:
- Have any of the following: intellectual disability; untreated bipolar disorder; untreated schizophrenia and other psychotic disorders; and untreated alcohol and substance use disorders, report a suicide attempt in the last 3 months, or current suicide intent and/or plans.
- Not be living with the child at least 50% of the time.
- Not have sufficient proficiency in English to complete assessments and participate in treatment.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Experimental: Supportive Parenting for Anxious Childhood Emotions (SPACE)
Parent-only approach to treating anxiety disorders in adolescents delivered over 16-20 sessions. |
Parent-based treatment delivered by therapist for 16-20 weekly sessions. |
|
Comparador Ativo: Nutritional Support (NS)
Parent-only approach comparator arm delivered over 16-20 sessions. |
Nutritional Support from Registered Dietician for 16-20 weekly sessions with parents. |
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Pica, ARFID, and Rumination Disorder Interview (PARDI-C/P)
Prazo: Weeks 1 and 16-20
|
This semi-structured clinical interview will assess ARFID presence and severity. Symptoms are rated on a 0 (no symptoms) to 6 (severe symptoms) scale. It yields an overall severity score and three profile scores (sensory sensitivity, lack of interest in eating or food, fear of aversive consequences). Score range = 0 to 6 with higher scores indicating greater severity. |
Weeks 1 and 16-20
|
|
Nine-Item Avoidant/Restrictive Food Intake Disorder Screen - Parent and Child Report (NIAS-C/P)
Prazo: Weeks 1, 8-10, 16-20 and 6 months later
|
This measure is a screener of ARFID severity. It contains 9 items, each rated on a 6-point scale from 0 ("strongly disagree") to 5 ("strongly agree"). It yields a total score and three subscale scores (picky/selective eating, poor appetite/limited interest, fear of negative consequences). Total score range = 0 to 45, with higher scores indicating greater severity. |
Weeks 1, 8-10, 16-20 and 6 months later
|
|
Clinical Global Impression Scale - Severity (CGI-S) and Improvement (CGI-I)
Prazo: Weeks 1 and 16-20
|
This measure will be used to assess overall severity (CGI-S) and improvement (CGI-I) in adolescent ARFID. Total score range for each is 1-7. (Scores of 1 ("very much improved/normal") or 2 ("much improved/borderline ill") indicate a positive treatment response; all other responses are considered negative responses. Higher scores indicate worse outcome. |
Weeks 1 and 16-20
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Children's Food Neophobia Scale - six item version (CFNS-6)
Prazo: Weeks 1, 8-10, 16-20 and 6 months later
|
This measure of children's reluctance to try new or unfamiliar foods contains 6 items rated on a 4-point scale from 1 ("strongly disagree") to 4 ("strongly agree"), with 2 items reverse-scored. Total score range = 1 to 24, with higher scores indicating greater food neophobia. |
Weeks 1, 8-10, 16-20 and 6 months later
|
|
Caregiver Strain Questionnaire (CGSQ)
Prazo: Weeks 1, 8-10, 16-20 and 6 months later
|
This scale will measure the strain caregivers experience as a result of their child's emotional and behavioral problems. It contains 21 items, each rated on a 5-point scale from 1 ("not at all a problem") to 5 ("very much a problem") for how much each occurrence or feeling was a problem in the past 6 months. The items form three subscales: objective strain (11 items), subjective internalized strain (6 items), and subjective externalized strain (4 items). Subscale and global scores are item means, 1 item ("relating well to child") is reverse scored. Scores range = 1 to 5, with higher scores indicating greater strain. |
Weeks 1, 8-10, 16-20 and 6 months later
|
|
Parent-Rated Food Flexibility Scale (FFS)
Prazo: Weeks 1, 8-10, 16-20 and 6 months later
|
This scale is a 10-item parent-report measure of the child's tolerance of variability across food-related domains. Parents rate each domain on a 5-point scale from 0 ("very inflexible") to 4 ("very flexible"), with "mostly inflexible" (1), "some flexibility" (2), and "mostly flexible" (3) in between. Ratings are summed to a total score (range = 0 to 40), with higher scores indicating greater flexibility. |
Weeks 1, 8-10, 16-20 and 6 months later
|
|
Acceptance and Confidence Scale - Anxiety
Prazo: Weeks 1, 8-10, 16-20 and 6 months later
|
This scale is a measure of the extent to which parents express acceptance of and confidence in the face of their child's anxiety, a key clinical target of SPACE. It contains 8 items, each rated on a 6-point scale from 1 ("strongly disagree") to 6 ("strongly agree"). Total score range = 8 to 48, with higher scores indicating greater acceptance and confidence. |
Weeks 1, 8-10, 16-20 and 6 months later
|
|
Weekly Food Update
Prazo: Weeks 1-20
|
This brief questionnaire tracks changes in the child's eating over the course of treatment. Parents complete it before each weekly session, thinking back over the past week. The form has two parts. In the first, parents indicate whether their child ate each food already being tracked, and if so, how much (a taste, some, or a full portion), and whether the child now eats it regularly. In the second, parents record foods that are new that week: foods the child has never eaten before, foods the child is eating again after a long period of avoidance, and familiar foods eaten in a new way (for example, a different brand, preparation, or setting). |
Weeks 1-20
|
|
Parent-completed Glasgow Sensory Questionnaire, short form (rGSQ-P)
Prazo: Weeks 1, 8-10, 16-20 and 6 months later
|
This scale has 24 items and measures children's sensory hyper- and hypo-sensitivity across six sense domains (visual, auditory, gustatory, olfactory, tactile, vestibular). Parents rate items on a 5-point scale from 0 ("never") to 4 ("always"), yielding total (0-96), hyper-sensitivity (0-48), and hypo-sensitivity (0-48) scores, with higher scores indicating greater sensory sensitivity. |
Weeks 1, 8-10, 16-20 and 6 months later
|
|
Client Satisfaction Questionnaire (CSQ-8)
Prazo: Week 16-20
|
This 8-item measure assesses client satisfaction. Parents and adolescents rate items on a 0-4 scale, with higher summed scores indicating greater satisfaction with services (range = 0 to 32). |
Week 16-20
|
Outras medidas de resultado
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Family Accommodation Scale - Anxiety (FASA-C/P)
Prazo: Weeks 1 and 16-20
|
This scale is a widely used measure of family accommodation. Adolescents and parents rate 9 items on a 5-point scale from 0 ("never") to 4 ("daily"). Total score range = 0 to 36. |
Weeks 1 and 16-20
|
|
Family Assessment Device - General Functioning Scale (FAD-GF)
Prazo: Weeks 1 and 16-20
|
This scale measures overall family functioning. Adolescents and parents rate 12-items on a 4-point scale from 0 ("strongly disagree") to 3 ("strongly agree"). Total score range = 0 to 36. |
Weeks 1 and 16-20
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Eli Lebowitz, Yale University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Início do estudo
Conclusão Primária (Estimado)
Conclusão Primária
Conclusão do estudo (Estimado)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
Outros números de identificação do estudo
- 2000044082
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .